0001140361-18-010828.txt : 20180228 0001140361-18-010828.hdr.sgml : 20180228 20180228164506 ACCESSION NUMBER: 0001140361-18-010828 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180226 FILED AS OF DATE: 20180228 DATE AS OF CHANGE: 20180228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KARSEN PERRY A CENTRAL INDEX KEY: 0001260573 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35993 FILM NUMBER: 18651872 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc CENTRAL INDEX KEY: 0001302573 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383572512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-995-8200 MAIL ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc1.xml FORM 4 X0306 4 2018-02-26 0 0001302573 OncoMed Pharmaceuticals Inc OMED 0001260573 KARSEN PERRY A C/O ONCOMED PHARMACEUTICALS, INC. 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 1 0 0 0 Common Stock 2018-02-26 4 A 0 70500 0.00 A 80500 D Stock Option (Right to Buy) 2.29 2018-02-26 4 A 0 120000 0.00 A 2028-02-26 Common Stock 120000 120000 D Grant of Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof. The option vests with respect to 1/6 of the shares subject thereto on each monthly anniversary of January 3, 2018, subject to the Reporting Person's continued service to the Issuer as Executive Chairman through each such vesting date. /s/ Alicia Hager, Attorney-in-Fact for Perry A. Karsen 2018-02-28